MBX Biosciences, Inc (NASDAQ:MBX) IPO will take place September, 13 on the NASDAQ exchange under the ticker MBX.
The company is offering shares at an expected price between $14.00 and $16.00 per share with an insider lock-up period of 180 days ending on March 12, 2025.
See also: Benzinga IPO Calendar
About MBX Biosciences, Inc
MBX Biosciences, Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders.
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.